Clinical Trials Logo
  1. Home
  2. Rhinosinusitis
  3. NCT00849953
  4. Details
NCT00849953 Clinical Trial

FinESS Registry Study

Rhinosinusitis Clinical Trial

Official title:
FinESS Registry Study

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00849953
Other study ID # 1498-001
Secondary ID
Status Completed
Phase N/A
First received February 20, 2009
Last updated June 27, 2011
Start date March 2009
Est. completion date March 2011

Study information
Verified date June 2011
Source Entellus Medical, Inc.
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug Administration
Study type Observational

Clinical Trial Summary

A prospective, post-approval registry study assessing subject rhinosinusitis symptomatic status over time following treatment with FinESS Sinus Treatment using self-administered quality of life survey data.

Recruitment information / eligibility
Status Completed
Enrollment 500
Est. completion date March 2011
Est. primary completion date March 2011
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- adults 18 years or older undergoing balloon dilation with FinESS Sinus Treatment and have provided voluntary consent to participate in Registry

Exclusion Criteria:

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Locations
Country Name City State
United States Austin Ear, Nose and Throat Clinic Austin Texas
United States Capital Otolaryngology Austin Texas
United States Texas Sinus Center Boerne Texas
United States South Denver ENT and Allergy Denver Colorado
United States Dickson Ear, Nose and Throat PLC Dickson Tennessee
United States Gensys Regional Medical Center Grand Blanc Michigan
United States Medical Center ENT Associates of Houston Houston Texas
United States Lee's Summit Ear, Nose and Throat Center Lee's Summit Missouri
United States Paparella Group Maple Grove Minnesota
United States Advanced Ear, Nose and Throat Specialists Milwaukee Wisconsin
United States Gulf Coast Facial Plastics and ENR Panama City Florida
United States Advanced Otolaryngology, PC Richmond Virginia
United States Midwest Ear, Nose and Throat Sioux Falls South Dakota
United States St. Cloud Ear Nose and Throat St Cloud Minnesota

Sponsors (1)
Lead Sponsor Collaborator
Entellus Medical, Inc.

Country where clinical trial is conducted

United States, 

See also
  Status Clinical Trial Phase
Not yet recruiting NCT02636790 - Early Versus Late Surgical Wait Times Early Phase 1
Completed NCT02712502 - Levofloxacin in Bacterial Rhinosinussitis N/A
Completed NCT00986830 - Healthcare Utilization and Outcomes of FinESS Treatment in the Office N/A
Completed NCT00534079 - Nasal Inhalation of Pulmozyme in Patients With Cystic Fibrosis and Chronic Rhinosinusitis Phase 3
Completed NCT05442606 - Physiotherapy Protocol in Treating Chronic Rhinosinusitis N/A
Completed NCT01955980 - Buparid/PARI SINUS Versus Budes® Nasal Spray in the Therapy of Chronic Rhinosinusitis Phase 1/Phase 2
Completed NCT04123405 - Efficacy and Safety of Acetylcysteine for the Treatment of Acute Uncomplicated Rhinosinusitis Phase 3
Completed NCT00797004 - Olfactory Dysfunction of Rhinosinusitis N/A
Recruiting NCT05494346 - Safety and Performance Assessment of the Decongestant Seawater Spray Pocket Valve Enriched With Essential Oils in Patients With Acute Rhinitis Associated With Nasal Obstruction N/A
Not yet recruiting NCT05836935 - Role of Imaging in Complications of Sinusitis N/A
Withdrawn NCT02097576 - Manuka Honey Nasal Rinse Study N/A
Completed NCT01132781 - Theophylline in Rhinitis Phase 2
Recruiting NCT00948519 - Laser Assisted Treatment of Chronic Sinusitis With and Without Light Activated Agents N/A
Completed NCT00554190 - Study to Evaluate Safety and Effectiveness of AdvaCoat Sinus Gel Phase 4
Recruiting NCT03729258 - Efficacy and Safety of Modified Release Cefpodoxime Formulation in the Treatment of Acute Sinusitis. Phase 3
Withdrawn NCT03729310 - Comparison of Two Steroid Nasal Implants Following Endoscopic Sinus Surgery for Chronic Rhinosinusitis Early Phase 1
Recruiting NCT01296919 - The Clinical Significance of the Uncinate Process Histopathology in Chronic Rhinosinusitis N/A
Completed NCT01086839 - Sino-nasal Inhalation of Sodium Chloride 6,0% in Patients With Cystic Fibrosis and Chronic Rhinosinusitis N/A
Withdrawn NCT00669799 - Topical Antibiotic Use In Chronic Rhinosinusitis A Double-Blinded, Randomized, Placebo Controlled Study N/A
Completed NCT03229551 - Xylitol for Chronic Sinusitis Phase 2/Phase 3